Egle Therapeutics SAS is a clinical-stage biotechnology company headquartered in Paris, France, that develops precision medicines designed to modulate regulatory T cells.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Egle Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Egle Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.